|
Home Page
About Us
Investors
Inventors
Portfolio
3DR Laboratories, LLC
AllTranz Inc.
AnosiaVax, Inc.
ApoImmune, Inc.
EndoProtech, Inc.
Eyevation, LLC
ImmunoTheragnostics Incorporated
InnoRem, Inc.
Intrepid Bioinformatics, Inc.
PGxl Laboratories, LLC
Pradama Inc.
RhinoCyte, Inc.
TrackFive Diagnostics, Inc.
ULSD, LLC
Contact Us
Privacy Policy
|
|
|
|
Portfolio - Eyevation, LLC
| Incorporated: |
|
1Q 2009
|
| Contacts: |
|
Jessica Sharon
|
Scientific Founder:
|
|
Norman Radtke, M.D.
|
| Description: |
|
Eyevation, LLC is a medical device company
focused on improving the treatment of retinal
degenerative diseases. Initial product is a surgical
instrument for treating these diseases. Eyevation
is also evaluating multiple novel treatments for
retinal degenerative diseases.
Company formed in partnership with MetaCyte, 1Q09
Refining initial instrument design for clinical applicability
Collaborating with the UofL Speed School of Engineering and Sullivan College of Pharmacy for nanoplate development
|
|
|
